Archives: 2019-08-23

South Korea to revise bill to enable gene therapy research using gene editing

South Korea is seeking to ease legislative restrictions to allow research on breakthrough gene therapies using gene editing and other advanced gene correction tools. The Ministry of Health and Welfare said on Thursday it is revising the Bioethics Act to allow gene therapy research in this direction.  Rep. Yoon Il-kyu of the ruling Democratic Party,

Read More


Moving Towards Automated Manufacturing for Cell Therapies

As more cell therapy products reach the “finish line” of U.S. Food and Drug Administration (FDA) approval and new regenerative medicine products begin the clinical development process, the need for expanded manufacturing capacity that can support long-term commercial business models is increasing. Recently, David Smith, Alex Klarer, Thomas Heathman, Courtney LeBlon, Yasuhiko Tada and Brian

Read More


FDA and Congress Move to Stop Unproven Stem Cell Interventions

Agency’s jurisdiction over regenerative therapies upheld in landmark court ruling The Food and Drug Administration and members of Congress have taken important steps in recent months to protect consumers from unproven and risky stem cell products offered by hundreds of clinics nationwide. However, the agency needs to take broader action to deter businesses from selling

Read More


Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina

Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would

Read More


NGen Supercluster starts with project to scale the production of treatments for cancers and rare diseases

iVexSol’s project will tackle the cost and shortages of these treatments through high-volume production solution Source Innovation, Science and Economic Development Canada Through the Innovation Superclusters Initiative, the Government of Canada is taking immediate and targeted action to build on Canada’s existing strengths to help our companies and their workers get ahead in the global

Read More


Precision Medicine Trials and Molecular Testing Guidelines Expand to Reach More Patients

The Lung Cancer Master Protocol (Lung-MAP), a large precision medicine umbrella trial supported by the National Cancer Institute (NCI) and their partners, has opened the trial to include advanced-stage patients with all non–small cell lung cancers (NSCLCs). To accommodate these new trial patients, the NCI has also made further changes to the trial’s protocol.  The

Read More


Gene Therapy Market Research Explores The Key Success Factors And Business Opportunities Including Key Players Forecast Till 2026

Source Transparency Market Research Gene Therapy Market – Snapshot The global gene therapy market is expanding at an exponential pace due to promising therapeutic outcomes of gene therapy, high prevalence and rise in incidence of cancer, and large number of clinical research pipeline products. In terms of revenue, the market was valued at US$ 17.0

Read More